[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].
Identifieur interne : 000569 ( PubMed/Corpus ); précédent : 000568; suivant : 000570[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].
Auteurs : L V Ozerova ; I E Stepanian ; V V Romanov ; T A KireevaSource :
- Problemy tuberkuleza [ 0032-9533 ] ; 1989.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (administration & dosage), Adrenal Cortex Hormones (therapeutic use), Adult, Aspirin (therapeutic use), Azathioprine (administration & dosage), Azathioprine (therapeutic use), Chloroquine (therapeutic use), Drug Administration Schedule, Drug Combinations (therapeutic use), Drug Evaluation, Drug Therapy, Combination, Female, Humans, Lung Diseases (drug therapy), Lymphatic Diseases (drug therapy), Male, Middle Aged, Prednisolone (therapeutic use), Sarcoidosis (drug therapy), Triamcinolone Acetonide (therapeutic use).
- MESH :
- chemical , administration & dosage : Adrenal Cortex Hormones, Azathioprine.
- chemical , therapeutic use : Adrenal Cortex Hormones, Aspirin, Azathioprine, Chloroquine, Drug Combinations, Prednisolone, Triamcinolone Acetonide.
- drug therapy : Lung Diseases, Lymphatic Diseases, Sarcoidosis.
- Adult, Drug Administration Schedule, Drug Evaluation, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.
Abstract
One hundred and seventeen patients with active sarcoidosis of the respiratory organs were treated according to 4 therapy regimens based on the use of corticosteroid drugs. Intermittent use of the corticosteroids was shown to be the most efficient (in 98.5 per cent). It allowed to lower the course dose by 25-30 per cent and to reduce the frequency of complications to 1.5 per cent. Inspite of high efficacy of kenalog 40, its use was limited because of adverse reactions in 19.2 per cent of the patients. It was difficult to eliminate the adverse reactions because of the drug prolonged action. The use of presocyl provided improvement in 62 per cent of the patients having contraindications for corticosteroid therapy. Patients with marked pneumosclerotic lesions should be treated with simultaneous use of corticosteroids and azathioprine.
PubMed: 2726708
Links to Exploration step
pubmed:2726708Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].</title><author><name sortKey="Ozerova, L V" sort="Ozerova, L V" uniqKey="Ozerova L" first="L V" last="Ozerova">L V Ozerova</name></author><author><name sortKey="Stepanian, I E" sort="Stepanian, I E" uniqKey="Stepanian I" first="I E" last="Stepanian">I E Stepanian</name></author><author><name sortKey="Romanov, V V" sort="Romanov, V V" uniqKey="Romanov V" first="V V" last="Romanov">V V Romanov</name></author><author><name sortKey="Kireeva, T A" sort="Kireeva, T A" uniqKey="Kireeva T" first="T A" last="Kireeva">T A Kireeva</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1989">1989</date><idno type="RBID">pubmed:2726708</idno><idno type="pmid">2726708</idno><idno type="wicri:Area/PubMed/Corpus">000569</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000569</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].</title><author><name sortKey="Ozerova, L V" sort="Ozerova, L V" uniqKey="Ozerova L" first="L V" last="Ozerova">L V Ozerova</name></author><author><name sortKey="Stepanian, I E" sort="Stepanian, I E" uniqKey="Stepanian I" first="I E" last="Stepanian">I E Stepanian</name></author><author><name sortKey="Romanov, V V" sort="Romanov, V V" uniqKey="Romanov V" first="V V" last="Romanov">V V Romanov</name></author><author><name sortKey="Kireeva, T A" sort="Kireeva, T A" uniqKey="Kireeva T" first="T A" last="Kireeva">T A Kireeva</name></author></analytic><series><title level="j">Problemy tuberkuleza</title><idno type="ISSN">0032-9533</idno><imprint><date when="1989" type="published">1989</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (administration & dosage)</term><term>Adrenal Cortex Hormones (therapeutic use)</term><term>Adult</term><term>Aspirin (therapeutic use)</term><term>Azathioprine (administration & dosage)</term><term>Azathioprine (therapeutic use)</term><term>Chloroquine (therapeutic use)</term><term>Drug Administration Schedule</term><term>Drug Combinations (therapeutic use)</term><term>Drug Evaluation</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Lung Diseases (drug therapy)</term><term>Lymphatic Diseases (drug therapy)</term><term>Male</term><term>Middle Aged</term><term>Prednisolone (therapeutic use)</term><term>Sarcoidosis (drug therapy)</term><term>Triamcinolone Acetonide (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Azathioprine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Aspirin</term><term>Azathioprine</term><term>Chloroquine</term><term>Drug Combinations</term><term>Prednisolone</term><term>Triamcinolone Acetonide</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lung Diseases</term><term>Lymphatic Diseases</term><term>Sarcoidosis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Drug Administration Schedule</term><term>Drug Evaluation</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">One hundred and seventeen patients with active sarcoidosis of the respiratory organs were treated according to 4 therapy regimens based on the use of corticosteroid drugs. Intermittent use of the corticosteroids was shown to be the most efficient (in 98.5 per cent). It allowed to lower the course dose by 25-30 per cent and to reduce the frequency of complications to 1.5 per cent. Inspite of high efficacy of kenalog 40, its use was limited because of adverse reactions in 19.2 per cent of the patients. It was difficult to eliminate the adverse reactions because of the drug prolonged action. The use of presocyl provided improvement in 62 per cent of the patients having contraindications for corticosteroid therapy. Patients with marked pneumosclerotic lesions should be treated with simultaneous use of corticosteroids and azathioprine.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2726708</PMID><DateCompleted><Year>1989</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0032-9533</ISSN><JournalIssue CitedMedium="Print"><Issue>3</Issue><PubDate><Year>1989</Year></PubDate></JournalIssue><Title>Problemy tuberkuleza</Title><ISOAbbreviation>Probl Tuberk</ISOAbbreviation></Journal><ArticleTitle>[Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].</ArticleTitle><Pagination><MedlinePgn>37-41</MedlinePgn></Pagination><Abstract><AbstractText>One hundred and seventeen patients with active sarcoidosis of the respiratory organs were treated according to 4 therapy regimens based on the use of corticosteroid drugs. Intermittent use of the corticosteroids was shown to be the most efficient (in 98.5 per cent). It allowed to lower the course dose by 25-30 per cent and to reduce the frequency of complications to 1.5 per cent. Inspite of high efficacy of kenalog 40, its use was limited because of adverse reactions in 19.2 per cent of the patients. It was difficult to eliminate the adverse reactions because of the drug prolonged action. The use of presocyl provided improvement in 62 per cent of the patients having contraindications for corticosteroid therapy. Patients with marked pneumosclerotic lesions should be treated with simultaneous use of corticosteroids and azathioprine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozerova</LastName><ForeName>L V</ForeName><Initials>LV</Initials></Author><Author ValidYN="Y"><LastName>Stepanian</LastName><ForeName>I E</ForeName><Initials>IE</Initials></Author><Author ValidYN="Y"><LastName>Romanov</LastName><ForeName>V V</ForeName><Initials>VV</Initials></Author><Author ValidYN="Y"><LastName>Kireeva</LastName><ForeName>T A</ForeName><Initials>TA</Initials></Author></AuthorList><Language>rus</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Effektivnost' razlichnykh rezhimov medikamentoznogo lecheniia bol'nykh sarkoidozom organov dykhaniia.</VernacularTitle></Article><MedlineJournalInfo><Country>Russia (Federation)</Country><MedlineTA>Probl Tuberk</MedlineTA><NlmUniqueID>0414141</NlmUniqueID><ISSNLinking>0032-9533</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>78456-99-2</RegistryNumber><NameOfSubstance UI="C014772">presocyl</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>F446C597KA</RegistryNumber><NameOfSubstance UI="D014222">Triamcinolone Acetonide</NameOfSubstance></Chemical><Chemical><RegistryNumber>MRK240IY2L</RegistryNumber><NameOfSubstance UI="D001379">Azathioprine</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="N">Aspirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001379" MajorTopicYN="N">Azathioprine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004341" MajorTopicYN="N">Drug Evaluation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008206" MajorTopicYN="N">Lymphatic Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014222" MajorTopicYN="N">Triamcinolone Acetonide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2726708</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000569 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000569 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:2726708
|texte= [Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:2726708" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |